Dr Nicola Logan
- Affiliate (Undergraduate Medical School)
email:
Nicola.Logan.2@glasgow.ac.uk
School of Medicine, Dentistry & Nursing, General Practice & Primary Care, Wolfson Medical School Building, Gilmorehill Campus
Publications
2022
Tyson, Grace B., Jones, Sarah, Logan, Nicola, McDonald, Michael, Murcia, Pablo R. 
ORCID: https://orcid.org/0000-0002-4352-394X, Willett, Brian J. ORCID: https://orcid.org/0000-0001-8912-3266, Weir, William and Hosie, Margaret J. ORCID: https://orcid.org/0000-0002-4313-5023
(2022)
Rising SARS-CoV-2 seroprevalence and patterns of cross-variant antibody neutralization in UK domestic cats.
bioRxiv,
(doi: 10.1101/2022.11.18.517046)
Willett, B. J. et al. (2022) Distinct antigenic properties of the SARS-CoV-2 Omicron lineages BA.4 and BA.5. bioRxiv, (doi: 10.1101/2022.05.25.493397)
2021
Sziemel, Agnieszka M., Hwa, Shi-Hsia, Sigal, Alex, Tyson, Grace, Logan, Nicola, Willett, Brian J. ORCID: https://orcid.org/0000-0001-8912-3266 and Durcan, Peter J.
(2021)
Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351.
bioRxiv,
(doi: 10.1101/2021.04.11.439360)
Articles
Tyson, Grace B., Jones, Sarah, Logan, Nicola, McDonald, Michael, Murcia, Pablo R. ORCID: https://orcid.org/0000-0002-4352-394X, Willett, Brian J. ORCID: https://orcid.org/0000-0001-8912-3266, Weir, William and Hosie, Margaret J. ORCID: https://orcid.org/0000-0002-4313-5023
(2022)
Rising SARS-CoV-2 seroprevalence and patterns of cross-variant antibody neutralization in UK domestic cats.
bioRxiv,
(doi: 10.1101/2022.11.18.517046)
Willett, B. J. et al. (2022) Distinct antigenic properties of the SARS-CoV-2 Omicron lineages BA.4 and BA.5. bioRxiv, (doi: 10.1101/2022.05.25.493397)
Sziemel, Agnieszka M., Hwa, Shi-Hsia, Sigal, Alex, Tyson, Grace, Logan, Nicola, Willett, Brian J. ORCID: https://orcid.org/0000-0001-8912-3266 and Durcan, Peter J.
(2021)
Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351.
bioRxiv,
(doi: 10.1101/2021.04.11.439360)